Clinical presentation and management of severe Ebola virus disease

Annals of the American Thoracic Society

Volumn 11, Issue 9, 2014, Pages 1341-1350

  West, T Eoin ^a,c,d   Von Saint André Von Arnim, Amélie ^b,c  

^a Division of Pulmonary and Critical Care Medicine   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Critical illness; Disease outbreaks; Ebola virus disease; Infection control; Intensive care

Indexed keywords

ACUTE KIDNEY FAILURE; ANALGESIA; ANOREXIA; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL FEATURE; DEHYDRATION; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; EBOLA VIRUS DISEASE; ELECTROLYTE DISTURBANCE; EXPERIMENTAL THERAPY; FATALITY; FATIGUE; FEVER; FILOVIRUS INFECTION; HEALTH CARE PERSONNEL; HOSPITAL DISCHARGE; HUMAN; HYPOCALCEMIA; HYPOKALEMIA; HYPONATREMIA; INFECTION CONTROL; MIXED INFECTION; NUTRITION; PATHOPHYSIOLOGY; PSYCHOSOCIAL CARE; RESPIRATORY FAILURE; RESUSCITATION; SAFETY; SHOCK; SUPERINFECTION; TERMINAL CARE; VASCULAR ACCESS; VOMITING; ACUTE KIDNEY INJURY; BLOOD COAGULATION DISORDERS; BRAIN DISEASES; CENTRAL VENOUS CATHETERIZATION; CRITICAL ILLNESS; DIAGNOSTIC PROCEDURE; DISEASE TRANSMISSION; ETHICS; HEMORRHAGIC FEVER, EBOLA; INTENSIVE CARE; MALNUTRITION; PHYSIOLOGIC MONITORING; PREVENTION AND CONTROL; PROTECTIVE EQUIPMENT; RESPIRATORY INSUFFICIENCY; SOCIAL SUPPORT; TRANSMISSION; WATER-ELECTROLYTE IMBALANCE; WORLD HEALTH ORGANIZATION;

ACUTE KIDNEY INJURY; BLOOD COAGULATION DISORDERS; BRAIN DISEASES; CARDIOPULMONARY RESUSCITATION; CATHETERIZATION, CENTRAL VENOUS; CLINICAL LABORATORY TECHNIQUES; CRITICAL ILLNESS; HEMORRHAGIC FEVER, EBOLA; HUMANS; INFECTION CONTROL; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; INTENSIVE CARE; MALNUTRITION; MONITORING, PHYSIOLOGIC; PAIN MANAGEMENT; PATIENT DISCHARGE; PROTECTIVE DEVICES; RESPIRATORY INSUFFICIENCY; SHOCK; SOCIAL SUPPORT; TERMINAL CARE; WATER-ELECTROLYTE IMBALANCE; WORLD HEALTH ORGANIZATION;

EID: 84914665733     PISSN: 23296933     EISSN: 23256621     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201410-481PS     Document Type: Article

References (84)

1. N. Cumming-Bruce. W.H.O. Chief calls Ebola outbreak a 'crisis for international peace'. New York Times. [accessed 2014 Oct 13]. Available from: http://www.nytimes.com/2014/10/14/world/africa/ebola-virusoutbreak.html.
2. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow MS, Këita S, De Clerck H, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014;371: 1418-1425.
3. CDC. 2014. Ebola outbreak in West Africa: outbreak distribution map. [accessed 2014 Nov 2]. Available from: http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/distribution-map.html.
4. CDC. New modeling tool for response to Ebola virus disease. [accessed 2014 Oct 13]. Available from: http://www.cdc.gov/media/releases/2014/s0923-ebola-model-Factsheet.html.
5. WHO Ebola Response Team. Ebola virus disease in West Africa: The first 9 months of the epidemic and forward projections. N Engl J Med 2014;371:1481-1495.
6. WHO. Ebola virus disease. [accessed 2014 Oct 7]. Available from: http://www.who.int/mediacentre/factsheets/fs103/en/.
7. Kreuels B, Wichmann D, Emmerich P, Schmidt-Chanasit J, de Heer G, Kluge S, Sow A, Renné T, Gü nther S, Lohse AW, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med (In press).
8. Jeffs B, Roddy P, Weatherill D, de la Rosa O, Dorion C, Iscla M, Grovas I, Palma PP, Villa L, Bernal O, et al. The Medecins Sans Frontieres intervention in the Marburg hemorrhagic fever epidemic, Uige, Angola, 2005: I. Lessons learned in the hospital. J Infect Dis 2007; 196:S154-S161.
9. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011;377: 849-862.
10. Feldmann H. Ebola: A growing threat? N Engl J Med 2014;371: 1375-1378.
11. Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud- Soukate J, Debré P, Fisher-Hoch SP, McCormick JB, Georges AJ. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 1999;5:423-426.
12. Baize S, Leroy EM, Mavoungou E, Fisher-Hoch SP. Apoptosis in fatal Ebola infection. Does the virus toll the bell for immune system? Apoptosis 2000;5:5-7.
13. Geisbert TW, Hensley LE, Gibb TR, Steele KE, Jaax NK, Jahrling PB. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest 2000;80:171-186.
14. Ansari AA. Clinical features and pathobiology of Ebolavirus infection. J Autoimmun (In press).
15. Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, Lee WF, Spiropoulou CF, Ksiazek TG, Lukwiya M, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004;78:4330-4341.
16. Martines RB, Ng DL, Greer PW, Rollin PE, Zaki SR. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg Viruses. J Pathol (In press).
17. Bausch DG, Sprecher AG, Jeffs B, Boumandouki P. Treatment of Marburg and Ebola hemorrhagic fevers: A strategy for testing new drugs and vaccines under outbreak conditions. Antiviral Res 2008; 78:150-161.
18. Kortepeter MG, Bausch DG, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis 2011;204: S810-S816.
19. Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, Sealfon RS, Kanneh L, Moigboi A, Momoh M, et al.; the KGH Lassa Fever Program, the Viral Hemorrhagic Fever Consortium, and the WHO Clinical Response Team. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med (In press).
20. Fowler RA, Fletcher T, Fischer WA II, Lamontagne F, Jacob S, Brett- Major D, Lawler JV, Jacquerioz FA, Houlihan C, O'Dempsey T, et al. Caring for critically ill patients with Ebola virus disease. Perspectives from west Africa. Am J Respir Crit Care Med 2014;190:733-737.
21. Denizot M, Neal JW, Gasque P. Encephalitis due to emerging viruses: CNS innate immunity and potential therapeutic targets. J Infect 2012; 65:1-16.
22. Sonneville R, Verdonk F, Rauturier C, Klein IF, Wolff M, Annane D, Chretien F, Sharshar T. Understanding brain dysfunction in sepsis. Ann Intensive Care 2013;3:15.
23. Mupere E, Kaducu OF, Yoti Z. Ebola haemorrhagic fever among hospitalised children and adolescents in northern Uganda: epidemiologic and clinical observations. Afr Health Sci 2001;1: 60-65.
24. IDWeek. Ebola: lessons learned. 2014 [accessed 2014 Oct 23]. Available from: http://www.idweek.org/ebola-idweek-2014/.
25. WFAA. Presby doc on Ebola response: 'Epitome of health care'. [accessed 2014 Oct 23]. Available from: http://www.wfaa.com/story/news/health/2014/10/18/texas-health-presbyterian-doctor-talksabout-ebola-response/17483917/.
26. Richards GA, Murphy S, Jobson R, Mer M, Zinman C, Taylor R, Swanepoel R, Duse A, Sharp G, De La Rey IC, et al. Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit Care Med 2000;28:240-244.
27. Mupapa K, Mukundu W, Bwaka MA, Kipasa M, De Roo A, Kuvula K, Kibadi K, Massamba M, Ndaberey D, Colebunders R, et al. Ebola hemorrhagic fever and pregnancy. J Infect Dis 1999;179:S11-S12.
28. Jamieson DJ, Uyeki TM, Callaghan WM, Meaney-Delman D, Rasmussen SA. What obstetrician-gynecologists should know about Ebola: A perspective from the centers for disease control and prevention. Obstet Gynecol (In press).
29. Kuhn JH, Dodd LE, Wahl-Jensen V, Radoshitzky SR, Bavari S, Jahrling PB. Evaluation of perceived threat differences posed by filovirus variants. Biosecur Bioterror 2011;9:361-371.
30. New York Times. Ebola facts: What is being done to improve medical treatment in Africa? [accessed 2014 Nov 1]. Available from: http://www.nytimes.com/interactive/2014/07/31/world/africa/ebola-virusoutbreak-qa.html?-r=0.
31. Rollin PE, Bausch DG, Sanchez A. Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis 2007;196:S364-S371.
32. Sanchez A, Lukwiya M, Bausch D, Mahanty S, Sanchez AJ, Wagoner KD, Rollin PE. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol 2004;78: 10370-10377.
33. Villinger F, Rollin PE, Brar SS, Chikkala NF, Winter J, Sundstrom JB, Zaki SR, Swanepoel R, Ansari AA, Peters CJ. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis 1999;179:S188-S191.
34. Dowell SF. Ebola hemorrhagic fever: why were children spared? Pediatr Infect Dis J 1996;15:189-191.
35. McElroy AK, Erickson BR, Flietstra TD, Rollin PE, Nichol ST, Towner JS, Spiropoulou CF. Biomarker correlates of survival in pediatric patients with Ebola virus disease. Emerg Infect Dis 2014;20:1683-1690.
36. CDC. Case definition for Ebola virus disease (EVD). [accessed 2014 Oct 29]. Available from: http://www.cdc.gov/vhf/ebola/hcp/casedefinition.html.
37. Tattevin P, Durante-Mangoni E, Massaquoi M. Does this patient have Ebola virus disease? Intensive Care Med 2014;40:1738-1741.
38. WHO. Clinical management of patients with viral haemorrhagic fever: A pocket guide for the front-line health worker. [accessed 2014 Oct 6]. Available from: http://www.who.int/csr/resources/publications/clinical-management-patients/en/.
39. Drosten C, Gö ttig S, Schilling S, Asper M, Panning M, Schmitz H, G unther S. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Micro biol 2002;40: 2323-2330.
40. Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters CJ. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis 1999;179: S192-S198.
41. Towner JS, Sealy TK, Ksiazek TG, Nichol ST. High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis 2007;196: S205-S212.
42. CDC. Interim guidance for specimen collection, transport, testing, and submission for patients with suspected infection with Ebola virus disease. [accessed 2014 Oct 22]. Available from: http://www.cdc.gov/vhf/ebola/pdf/ebola-lab-guidance.pdf.
43. Roddy P, Howard N, Van Kerkhove MD, Lutwama J, Wamala J, Yoti Z, Colebunders R, Palma PP, Sterk E, Jeffs B, et al. Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008. PLoS ONE 2012;7:e52986.
44. Baker T. Critical care in low-income countries. Trop Med Int Health 2009;14:143-148.
45. Ortiz JR, Jacob ST, West TE. Clinical care for severe influenza and other severe illness in resource-limited settings: The need for evidence and guidelines. Influenza Other Respi Viruses 2013;7: 87-92.
46. Cheng AC, West TE, Limmathurotsakul D, Peacock SJ. Strategies to reduce mortality from bacterial sepsis in adults in developing countries. PLoS Med 2008;5:e175.
47. WHO. What we know about transmission of the Ebola virus among humans. [accessed 2014 Oct 29]. Available from: http://www.who.int/mediacentre/news/ebola/06-october-2014/en/.
48. CDC. Guidance on personal protective equipment to be used by healthcare workers during management of patients with Ebola virus disease in U.S. hospitals, including procedures for putting on (donning) and removing (doffing). [accessed 2014 Nov 2]. Available from: http://www.cdc.gov/vhf/ebola/hcp/procedures-for-ppe.html.
49. CDC. Q&As on transmission. [accessed 2014 Oct 29]. Available from: http://www.cdc.gov/vhf/ebola/transmission/qas.html.
50. Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, Nichol ST, Ksiazek TG, Rollin PE. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007; 196:S142-S147.
51. CDC. Information for healthcare workers and settings. [accessed 2014 Oct 29]. Available from: http://www.cdc.gov/vhf/ebola/hcp/index.html.
52. WHO. Information resources on Ebola virus disease. [accessed 2014 Oct 29]. Available from: http://www.who.int/csr/resources/publications/ebola/en/.
53. CDC. Ebola: Infection prevention and control recommendations for hospitalized patients with known or suspected Ebola virus disease in U.S. Hospitals. [accessed 2014 Oct 29]. Available from: http://www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-controlrecommendations.html.
54. Center for Infectious Disease Research and Policy. Commentary: health workers need optimal respiratory protection for Ebola. [accessed 2014 Nov 1]. Available from: http://www.cidrap.umn.edu/news-perspective/2014/09/commentary-health-workers-needoptimal-respiratory-protection-ebola.
55. Jaax N, Jahrling P, Geisbert T, Geisbert J, Steele K, McKee K, Nagley D, Johnson E, Jaax G, Peters C. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a bio containment laboratory. Lancet 1995;346:1669-1671.
56. Kobinger GP, Leung A, Neufeld J, Richardson JS, Falzarano D, Smith G, Tierney K, Patel A, Weingartl HM. Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs. J Infect Dis 2011;204:200-208.
57. Weingartl HM, Embury-Hyatt C, Nfon C, Leung A, Smith G, Kobinger G. Transmission of Ebola virus from pigs to non-human primates. Sci Rep 2012;2:811.
58. Roels TH, Bloom AS, Buffington J, Muhungu GL, Mac Kenzie WR, Khan AS, Ndambi R, Noah DL, Rolka HR, Peters CJ, et al. Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis 1999;179:S92-S97.
59. WHO. Infection prevention and control (IPC) guidance summary: Ebola guidance package. [accessed 2014 Oct 29]. Available from: http://www.who.int/csr/resources/publications/ebola/evd-guidancesummary/en/.
60. Decker BK, Sevransky JE, Barrett K, Davey RT, Chertow DS. Preparing for critical care services to patients with Ebola. Ann Intern Med (In press).
61. Lamontagne F, Clément C, Fletcher T, Jacob ST, Fischer WA II, Fowler RA. Doing today's work superbly well: Treating Ebola with current tools. N Engl J Med 2014;371:1565-1566.
62. PAHO. Recommendations for cholera clinical management. 2010 [accessed 2014 Nov 3]. Available from: http://www.paho.org/hq/index.php?option=com-content&view=category&layout=blog&id=3119&Itemid=3467.
63. Clark DV, Jahrling PB, Lawler JV. Clinical management of filovirus infected patients. Viruses 2012;4:1668-1686.
64. Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB. Cholera. Lancet 2012;379:2466-2476.
65. American Society of Nephrology. AN frequently asked questions (faqs) regarding Ebola virus disease and dialysis. [accessed 2014 Oct 29]. Available from: http://www.asn-online.org/news/2014/ASN-FAQs-Ebola-Virus-Disease-and-Dialysis.pdf.
66. CDC. Guidance on air medical transport for patients with Ebola virus disease. [accessed 2014 Oct 30]. Available from: http://www.cdc.gov/vhf/ebola/hcp/guidance-air-medical-transport-patients.html.
67. Extracorporeal Life Support Organization. [accessed 2014 Oct 29]. Available from: http://elsonet.org/images/pdf/ELSO-Ebola-Statement.pdf.
68. Enserink M. Infectious diseases: Ebola drugs still stuck in lab. Science 2014;345:364-365.
69. Bray M, Pilch R. Filoviruses: recent advances and future challenges. Expert Rev Anti Infect Ther 2006;4:917-921.
70. Chimerix. Chimerix announces emergency investigational new drug applications for brincidofovir authorized by FDA for patients with Ebola virus disease. [accessed 2014 Oct 7]. Available from: http://ir.chimerix.com/releasedetail.cfm?releaseid=874647.
71. Maurice J. WHO meeting chooses untried interventions to defeat Ebola. Lancet 2014;384:e45-e46.
72. WHO. Statement on the who consultation on potential Ebola therapies and vaccines. [accessed 2014 Oct 23]. Available from: http://www.who.int/mediacentre/news/statements/2014/ebola-therapiesconsultation/en/.
73. Mapp Biopharmaceutical. [accessed 2014 Oct 7]. Available from: http://www.mappbio.com/.
74. Tekmira. FDA modifies Tekmira's tkmebola clinical hold to partial hold. [accessed 2014 Oct 23]. Available from: http://investor.tekmirapharm.com/releasedetail.cfm?ReleaseID=865208.
75. Wellcome Trust. Ebola treatment trials to be fast-tracked in West Africa. [accessed 2014 Oct 7]. Available from: http://www.wellcome.ac.uk/News/Media-office/Press-releases/2014/WTP057419.htm.
76. WHO. Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease. [accessed 2014 Oct 7]. Available from: http://www.who.int/csr/resources/publications/ebola/convalescent-treatment/en/.
77. CDC. Recommendations for safely performing acute hemodialysis in patients with Ebola virus disease in U.S. hospitals. [accessed 2014 Oct 29]. Available from: http://www.cdc.gov/vhf/ebola/hcp/guidance-dialysis.html.
78. Canadian Critical Care Society. Ebola clinical care guidelines. [accessed 2014 Oct 28]. Available from: http://www.canadiancriticalcare.org.
79. Donovan GK. Ebola, epidemics, and ethics: what we have learned. Philos Ethics Humanit Med 2014;9:15.
80. Biddison LD, Berkowitz KA, Courtney B, De Jong CM, Devereaux AV, Kissoon N, Roxland BE, Sprung CL, Dichter JR, Christian MD, et al.; Task Force for Mass Critical Care; Task Force for Mass Critical Care. Ethical considerations: care of the critically ill and injured during pandemics and disasters. Chest consensus statement. Chest 2014; 146(Suppl)e145S-e155S.
81. Halpern SD, Becker D, Curtis JR, Fowler R, Hyzy R, Kaplan LJ, Rawat N, Sessler CN, Wunsch H, Kahn JM; Choosing Wisely Taskforce. An official American Thoracic Society/American Association Of Critical- Care Nurses/American College of Chest Physicians/Society of Critical Care Medicine Policy Statement: The choosing Wisely® top 5 list in critical care medicine. Am J Respir Crit Care Med 2014;190: 818-826.
82. Sprung CL, Truog RD, Curtis JR, Joynt GM, Baras M, Michalsen A, Briegel J, Kesecioglu J, Efferen L, De Robertis E, et al. Seeking worldwide professional consensus on the principles of end-of-life care for the critically ill. The consensus for worldwide end-of-life practice for patients in intensive care units (WELPICUS) study. Am J Respir Crit Care Med 2014;190:855-866.
83. WHO. Laboratory guidance for the diagnosis of Ebola virus disease. Interim recommendations. [accessed 2014 Oct 22]. Available from: http://apps.who.int/iris/bitstream/10665/134009/1/WHO-EVD-GUIDANCE-LAB-14.1-eng.pdf.
84. Rowe AK, Bertolli J, Khan AS, Mukunu R, Muyembe-Tamfum JJ, Bressler D, Williams AJ, Peters CJ, Rodriguez L, Feldmann H, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis 1999;179:S28-S35.